Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR mutation + CREBBP mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	cisplatin + vinorelbine tartrate Resistant: B - Late Trials cisplatin + vinorelbine tartrate Resistant : B	cisplatin + vinorelbine tartrate Resistant: B - Late Trials cisplatin + vinorelbine tartrate Resistant : B
EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	EGFR mutation + CREBBP mutation	Non Small Cell Lung Cancer	gefitinib Sensitive: B - Late Trials gefitinib Sensitive : B	gefitinib Sensitive: B - Late Trials gefitinib Sensitive : B
EGFR mutation + CREBBP mutation	Lung Non-Small Cell Squamous Cancer	EGFR mutation + CREBBP mutation	Lung Non-Small Cell Squamous Cancer	EGFR inhibitor + Tyrosine kinase inhibitor Resistant: C3 – Early Trials EGFR inhibitor + Tyrosine kinase inhibitor Resistant : C3	EGFR inhibitor + Tyrosine kinase inhibitor Resistant: C3 – Early Trials EGFR inhibitor + Tyrosine kinase inhibitor Resistant : C3